nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—ABCB1—colon cancer	0.383	1	CbGaD
Atazanavir—ABCC1—Irinotecan—colon cancer	0.108	0.215	CbGbCtD
Atazanavir—ABCC1—Vincristine—colon cancer	0.0943	0.188	CbGbCtD
Atazanavir—SLCO1B3—Methotrexate—colon cancer	0.0826	0.164	CbGbCtD
Atazanavir—ABCC1—Methotrexate—colon cancer	0.0571	0.114	CbGbCtD
Atazanavir—CYP2C9—Capecitabine—colon cancer	0.0434	0.0864	CbGbCtD
Atazanavir—ABCB1—Irinotecan—colon cancer	0.026	0.0518	CbGbCtD
Atazanavir—CYP2C9—Fluorouracil—colon cancer	0.0258	0.0512	CbGbCtD
Atazanavir—ABCB1—Vincristine—colon cancer	0.0228	0.0453	CbGbCtD
Atazanavir—CYP3A4—Irinotecan—colon cancer	0.0156	0.031	CbGbCtD
Atazanavir—ABCB1—Methotrexate—colon cancer	0.0138	0.0274	CbGbCtD
Atazanavir—CYP3A4—Vincristine—colon cancer	0.0136	0.0271	CbGbCtD
Atazanavir—Lopinavir—ABCB1—colon cancer	0.00092	0.404	CrCbGaD
Atazanavir—Ritonavir—ABCB1—colon cancer	0.000773	0.339	CrCbGaD
Atazanavir—Saquinavir—ABCB1—colon cancer	0.000586	0.257	CrCbGaD
Atazanavir—Flatulence—Irinotecan—colon cancer	0.000277	0.00248	CcSEcCtD
Atazanavir—Gastritis—Capecitabine—colon cancer	0.000276	0.00248	CcSEcCtD
Atazanavir—Muscular weakness—Capecitabine—colon cancer	0.000275	0.00247	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000275	0.00247	CcSEcCtD
Atazanavir—Alopecia—Fluorouracil—colon cancer	0.000273	0.00245	CcSEcCtD
Atazanavir—Back pain—Irinotecan—colon cancer	0.000272	0.00244	CcSEcCtD
Atazanavir—Abdominal distension—Capecitabine—colon cancer	0.000272	0.00244	CcSEcCtD
Atazanavir—Diabetes mellitus—Methotrexate—colon cancer	0.000267	0.0024	CcSEcCtD
Atazanavir—Agitation—Vincristine—colon cancer	0.000265	0.00238	CcSEcCtD
Atazanavir—Polyuria—Methotrexate—colon cancer	0.000265	0.00237	CcSEcCtD
Atazanavir—Photosensitivity—Methotrexate—colon cancer	0.000265	0.00237	CcSEcCtD
Atazanavir—Ill-defined disorder—Irinotecan—colon cancer	0.000261	0.00234	CcSEcCtD
Atazanavir—Malaise—Irinotecan—colon cancer	0.000253	0.00227	CcSEcCtD
Atazanavir—Neutropenia—Capecitabine—colon cancer	0.000252	0.00226	CcSEcCtD
Atazanavir—Syncope—Irinotecan—colon cancer	0.000252	0.00226	CcSEcCtD
Atazanavir—Convulsion—Vincristine—colon cancer	0.00025	0.00224	CcSEcCtD
Atazanavir—Hypertension—Vincristine—colon cancer	0.000249	0.00223	CcSEcCtD
Atazanavir—Loss of consciousness—Irinotecan—colon cancer	0.000247	0.00221	CcSEcCtD
Atazanavir—Photosensitivity reaction—Capecitabine—colon cancer	0.000246	0.00221	CcSEcCtD
Atazanavir—Myalgia—Vincristine—colon cancer	0.000246	0.0022	CcSEcCtD
Atazanavir—Weight increased—Capecitabine—colon cancer	0.000246	0.0022	CcSEcCtD
Atazanavir—Cough—Irinotecan—colon cancer	0.000245	0.0022	CcSEcCtD
Atazanavir—Weight decreased—Capecitabine—colon cancer	0.000244	0.00219	CcSEcCtD
Atazanavir—Hyperglycaemia—Capecitabine—colon cancer	0.000243	0.00218	CcSEcCtD
Atazanavir—Hypertension—Irinotecan—colon cancer	0.000243	0.00218	CcSEcCtD
Atazanavir—Depression—Capecitabine—colon cancer	0.00024	0.00215	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000239	0.00214	CcSEcCtD
Atazanavir—Renal failure—Capecitabine—colon cancer	0.000236	0.00212	CcSEcCtD
Atazanavir—Discomfort—Irinotecan—colon cancer	0.000236	0.00212	CcSEcCtD
Atazanavir—Neuropathy peripheral—Capecitabine—colon cancer	0.000236	0.00212	CcSEcCtD
Atazanavir—Oedema—Vincristine—colon cancer	0.000235	0.00211	CcSEcCtD
Atazanavir—Jaundice—Capecitabine—colon cancer	0.000234	0.0021	CcSEcCtD
Atazanavir—Stomatitis—Capecitabine—colon cancer	0.000234	0.0021	CcSEcCtD
Atazanavir—Infection—Vincristine—colon cancer	0.000234	0.0021	CcSEcCtD
Atazanavir—Urinary tract infection—Capecitabine—colon cancer	0.000234	0.0021	CcSEcCtD
Atazanavir—Convulsion—Fluorouracil—colon cancer	0.000233	0.00209	CcSEcCtD
Atazanavir—Confusional state—Irinotecan—colon cancer	0.000231	0.00207	CcSEcCtD
Atazanavir—Nervous system disorder—Vincristine—colon cancer	0.000231	0.00207	CcSEcCtD
Atazanavir—Haematuria—Capecitabine—colon cancer	0.000229	0.00206	CcSEcCtD
Atazanavir—Oedema—Irinotecan—colon cancer	0.000229	0.00206	CcSEcCtD
Atazanavir—Chest pain—Fluorouracil—colon cancer	0.000229	0.00205	CcSEcCtD
Atazanavir—Myalgia—Fluorouracil—colon cancer	0.000229	0.00205	CcSEcCtD
Atazanavir—Infection—Irinotecan—colon cancer	0.000228	0.00204	CcSEcCtD
Atazanavir—Hyperhidrosis—Vincristine—colon cancer	0.000228	0.00204	CcSEcCtD
Atazanavir—Hepatobiliary disease—Capecitabine—colon cancer	0.000228	0.00204	CcSEcCtD
Atazanavir—Discomfort—Fluorouracil—colon cancer	0.000226	0.00203	CcSEcCtD
Atazanavir—Shock—Irinotecan—colon cancer	0.000226	0.00202	CcSEcCtD
Atazanavir—Nervous system disorder—Irinotecan—colon cancer	0.000225	0.00202	CcSEcCtD
Atazanavir—Anorexia—Vincristine—colon cancer	0.000224	0.00201	CcSEcCtD
Atazanavir—Hyperhidrosis—Irinotecan—colon cancer	0.000222	0.00199	CcSEcCtD
Atazanavir—Confusional state—Fluorouracil—colon cancer	0.000221	0.00199	CcSEcCtD
Atazanavir—Mood swings—Methotrexate—colon cancer	0.00022	0.00197	CcSEcCtD
Atazanavir—Oedema—Fluorouracil—colon cancer	0.00022	0.00197	CcSEcCtD
Atazanavir—Anorexia—Irinotecan—colon cancer	0.000219	0.00196	CcSEcCtD
Atazanavir—Infection—Fluorouracil—colon cancer	0.000218	0.00196	CcSEcCtD
Atazanavir—Hepatitis—Capecitabine—colon cancer	0.000216	0.00194	CcSEcCtD
Atazanavir—Nervous system disorder—Fluorouracil—colon cancer	0.000215	0.00193	CcSEcCtD
Atazanavir—Hypoaesthesia—Capecitabine—colon cancer	0.000215	0.00193	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Vincristine—colon cancer	0.000214	0.00192	CcSEcCtD
Atazanavir—Urinary tract disorder—Capecitabine—colon cancer	0.000213	0.00191	CcSEcCtD
Atazanavir—Insomnia—Vincristine—colon cancer	0.000213	0.00191	CcSEcCtD
Atazanavir—Oedema peripheral—Capecitabine—colon cancer	0.000213	0.00191	CcSEcCtD
Atazanavir—Connective tissue disorder—Capecitabine—colon cancer	0.000212	0.0019	CcSEcCtD
Atazanavir—Urethral disorder—Capecitabine—colon cancer	0.000212	0.0019	CcSEcCtD
Atazanavir—Breast disorder—Methotrexate—colon cancer	0.00021	0.00188	CcSEcCtD
Atazanavir—Anorexia—Fluorouracil—colon cancer	0.000209	0.00188	CcSEcCtD
Atazanavir—Insomnia—Irinotecan—colon cancer	0.000207	0.00186	CcSEcCtD
Atazanavir—Decreased appetite—Vincristine—colon cancer	0.000205	0.00184	CcSEcCtD
Atazanavir—Dyspnoea—Irinotecan—colon cancer	0.000204	0.00183	CcSEcCtD
Atazanavir—Erythema multiforme—Capecitabine—colon cancer	0.000204	0.00183	CcSEcCtD
Atazanavir—Somnolence—Irinotecan—colon cancer	0.000204	0.00183	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Vincristine—colon cancer	0.000203	0.00182	CcSEcCtD
Atazanavir—Fatigue—Vincristine—colon cancer	0.000203	0.00182	CcSEcCtD
Atazanavir—Eye disorder—Capecitabine—colon cancer	0.000202	0.00181	CcSEcCtD
Atazanavir—Dyspepsia—Irinotecan—colon cancer	0.000202	0.00181	CcSEcCtD
Atazanavir—Tinnitus—Capecitabine—colon cancer	0.000201	0.00181	CcSEcCtD
Atazanavir—Pain—Vincristine—colon cancer	0.000201	0.00181	CcSEcCtD
Atazanavir—Constipation—Vincristine—colon cancer	0.000201	0.00181	CcSEcCtD
Atazanavir—Cardiac disorder—Capecitabine—colon cancer	0.0002	0.0018	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.0002	0.00179	CcSEcCtD
Atazanavir—Decreased appetite—Irinotecan—colon cancer	0.000199	0.00179	CcSEcCtD
Atazanavir—Eosinophilia—Methotrexate—colon cancer	0.000199	0.00178	CcSEcCtD
Atazanavir—Insomnia—Fluorouracil—colon cancer	0.000199	0.00178	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Irinotecan—colon cancer	0.000198	0.00178	CcSEcCtD
Atazanavir—Fatigue—Irinotecan—colon cancer	0.000198	0.00177	CcSEcCtD
Atazanavir—Pancreatitis—Methotrexate—colon cancer	0.000197	0.00177	CcSEcCtD
Atazanavir—Pain—Irinotecan—colon cancer	0.000196	0.00176	CcSEcCtD
Atazanavir—Constipation—Irinotecan—colon cancer	0.000196	0.00176	CcSEcCtD
Atazanavir—Angiopathy—Capecitabine—colon cancer	0.000196	0.00176	CcSEcCtD
Atazanavir—Dyspnoea—Fluorouracil—colon cancer	0.000196	0.00176	CcSEcCtD
Atazanavir—Somnolence—Fluorouracil—colon cancer	0.000195	0.00175	CcSEcCtD
Atazanavir—Immune system disorder—Capecitabine—colon cancer	0.000195	0.00175	CcSEcCtD
Atazanavir—Mediastinal disorder—Capecitabine—colon cancer	0.000195	0.00175	CcSEcCtD
Atazanavir—Dyspepsia—Fluorouracil—colon cancer	0.000193	0.00173	CcSEcCtD
Atazanavir—Gastrointestinal pain—Vincristine—colon cancer	0.000192	0.00173	CcSEcCtD
Atazanavir—Decreased appetite—Fluorouracil—colon cancer	0.000191	0.00171	CcSEcCtD
Atazanavir—Alopecia—Capecitabine—colon cancer	0.000191	0.00171	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00019	0.0017	CcSEcCtD
Atazanavir—Mental disorder—Capecitabine—colon cancer	0.000189	0.0017	CcSEcCtD
Atazanavir—Feeling abnormal—Irinotecan—colon cancer	0.000189	0.00169	CcSEcCtD
Atazanavir—Malnutrition—Capecitabine—colon cancer	0.000188	0.00169	CcSEcCtD
Atazanavir—Neutropenia—Methotrexate—colon cancer	0.000188	0.00168	CcSEcCtD
Atazanavir—Pain—Fluorouracil—colon cancer	0.000188	0.00168	CcSEcCtD
Atazanavir—Gastrointestinal pain—Irinotecan—colon cancer	0.000187	0.00168	CcSEcCtD
Atazanavir—Body temperature increased—Vincristine—colon cancer	0.000186	0.00167	CcSEcCtD
Atazanavir—Abdominal pain—Vincristine—colon cancer	0.000186	0.00167	CcSEcCtD
Atazanavir—Flatulence—Capecitabine—colon cancer	0.000185	0.00166	CcSEcCtD
Atazanavir—Erectile dysfunction—Methotrexate—colon cancer	0.000185	0.00166	CcSEcCtD
Atazanavir—Dysgeusia—Capecitabine—colon cancer	0.000184	0.00165	CcSEcCtD
Atazanavir—Photosensitivity reaction—Methotrexate—colon cancer	0.000183	0.00164	CcSEcCtD
Atazanavir—Back pain—Capecitabine—colon cancer	0.000182	0.00163	CcSEcCtD
Atazanavir—Abdominal pain—Irinotecan—colon cancer	0.000181	0.00163	CcSEcCtD
Atazanavir—Body temperature increased—Irinotecan—colon cancer	0.000181	0.00163	CcSEcCtD
Atazanavir—Feeling abnormal—Fluorouracil—colon cancer	0.000181	0.00162	CcSEcCtD
Atazanavir—Depression—Methotrexate—colon cancer	0.000179	0.0016	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000178	0.00159	CcSEcCtD
Atazanavir—Renal failure—Methotrexate—colon cancer	0.000176	0.00158	CcSEcCtD
Atazanavir—Stomatitis—Methotrexate—colon cancer	0.000175	0.00157	CcSEcCtD
Atazanavir—Ill-defined disorder—Capecitabine—colon cancer	0.000174	0.00156	CcSEcCtD
Atazanavir—Urticaria—Fluorouracil—colon cancer	0.000174	0.00156	CcSEcCtD
Atazanavir—Body temperature increased—Fluorouracil—colon cancer	0.000174	0.00156	CcSEcCtD
Atazanavir—Hypersensitivity—Vincristine—colon cancer	0.000173	0.00156	CcSEcCtD
Atazanavir—Sweating—Methotrexate—colon cancer	0.000172	0.00154	CcSEcCtD
Atazanavir—Haematuria—Methotrexate—colon cancer	0.000171	0.00153	CcSEcCtD
Atazanavir—Malaise—Capecitabine—colon cancer	0.00017	0.00152	CcSEcCtD
Atazanavir—Hepatobiliary disease—Methotrexate—colon cancer	0.000169	0.00152	CcSEcCtD
Atazanavir—Hypersensitivity—Irinotecan—colon cancer	0.000169	0.00152	CcSEcCtD
Atazanavir—Asthenia—Vincristine—colon cancer	0.000169	0.00152	CcSEcCtD
Atazanavir—Syncope—Capecitabine—colon cancer	0.000169	0.00151	CcSEcCtD
Atazanavir—Palpitations—Capecitabine—colon cancer	0.000166	0.00149	CcSEcCtD
Atazanavir—Loss of consciousness—Capecitabine—colon cancer	0.000165	0.00148	CcSEcCtD
Atazanavir—Asthenia—Irinotecan—colon cancer	0.000164	0.00148	CcSEcCtD
Atazanavir—Cough—Capecitabine—colon cancer	0.000164	0.00147	CcSEcCtD
Atazanavir—Hypertension—Capecitabine—colon cancer	0.000162	0.00146	CcSEcCtD
Atazanavir—Hypersensitivity—Fluorouracil—colon cancer	0.000162	0.00145	CcSEcCtD
Atazanavir—Diarrhoea—Vincristine—colon cancer	0.000161	0.00144	CcSEcCtD
Atazanavir—Hepatitis—Methotrexate—colon cancer	0.000161	0.00144	CcSEcCtD
Atazanavir—Arthralgia—Capecitabine—colon cancer	0.00016	0.00144	CcSEcCtD
Atazanavir—Chest pain—Capecitabine—colon cancer	0.00016	0.00144	CcSEcCtD
Atazanavir—Myalgia—Capecitabine—colon cancer	0.00016	0.00144	CcSEcCtD
Atazanavir—Anxiety—Capecitabine—colon cancer	0.000159	0.00143	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000159	0.00143	CcSEcCtD
Atazanavir—Urinary tract disorder—Methotrexate—colon cancer	0.000159	0.00142	CcSEcCtD
Atazanavir—Discomfort—Capecitabine—colon cancer	0.000158	0.00142	CcSEcCtD
Atazanavir—Urethral disorder—Methotrexate—colon cancer	0.000158	0.00141	CcSEcCtD
Atazanavir—Diarrhoea—Irinotecan—colon cancer	0.000157	0.00141	CcSEcCtD
Atazanavir—Dry mouth—Capecitabine—colon cancer	0.000157	0.0014	CcSEcCtD
Atazanavir—Dizziness—Vincristine—colon cancer	0.000156	0.0014	CcSEcCtD
Atazanavir—Pruritus—Fluorouracil—colon cancer	0.000155	0.00139	CcSEcCtD
Atazanavir—Confusional state—Capecitabine—colon cancer	0.000155	0.00139	CcSEcCtD
Atazanavir—Oedema—Capecitabine—colon cancer	0.000153	0.00138	CcSEcCtD
Atazanavir—Infection—Capecitabine—colon cancer	0.000152	0.00137	CcSEcCtD
Atazanavir—Erythema multiforme—Methotrexate—colon cancer	0.000152	0.00136	CcSEcCtD
Atazanavir—Dizziness—Irinotecan—colon cancer	0.000152	0.00136	CcSEcCtD
Atazanavir—Shock—Capecitabine—colon cancer	0.000151	0.00135	CcSEcCtD
Atazanavir—Nervous system disorder—Capecitabine—colon cancer	0.00015	0.00135	CcSEcCtD
Atazanavir—Eye disorder—Methotrexate—colon cancer	0.00015	0.00135	CcSEcCtD
Atazanavir—Diarrhoea—Fluorouracil—colon cancer	0.00015	0.00135	CcSEcCtD
Atazanavir—Tinnitus—Methotrexate—colon cancer	0.00015	0.00134	CcSEcCtD
Atazanavir—Vomiting—Vincristine—colon cancer	0.00015	0.00134	CcSEcCtD
Atazanavir—Cardiac disorder—Methotrexate—colon cancer	0.000149	0.00134	CcSEcCtD
Atazanavir—Skin disorder—Capecitabine—colon cancer	0.000149	0.00134	CcSEcCtD
Atazanavir—Rash—Vincristine—colon cancer	0.000148	0.00133	CcSEcCtD
Atazanavir—Hyperhidrosis—Capecitabine—colon cancer	0.000148	0.00133	CcSEcCtD
Atazanavir—Dermatitis—Vincristine—colon cancer	0.000148	0.00133	CcSEcCtD
Atazanavir—Headache—Vincristine—colon cancer	0.000147	0.00132	CcSEcCtD
Atazanavir—Anorexia—Capecitabine—colon cancer	0.000146	0.00131	CcSEcCtD
Atazanavir—Angiopathy—Methotrexate—colon cancer	0.000146	0.00131	CcSEcCtD
Atazanavir—Vomiting—Irinotecan—colon cancer	0.000146	0.00131	CcSEcCtD
Atazanavir—Immune system disorder—Methotrexate—colon cancer	0.000145	0.0013	CcSEcCtD
Atazanavir—Dizziness—Fluorouracil—colon cancer	0.000145	0.0013	CcSEcCtD
Atazanavir—Mediastinal disorder—Methotrexate—colon cancer	0.000145	0.0013	CcSEcCtD
Atazanavir—Rash—Irinotecan—colon cancer	0.000145	0.0013	CcSEcCtD
Atazanavir—Dermatitis—Irinotecan—colon cancer	0.000144	0.0013	CcSEcCtD
Atazanavir—Headache—Irinotecan—colon cancer	0.000144	0.00129	CcSEcCtD
Atazanavir—Alopecia—Methotrexate—colon cancer	0.000142	0.00127	CcSEcCtD
Atazanavir—Mental disorder—Methotrexate—colon cancer	0.000141	0.00126	CcSEcCtD
Atazanavir—Malnutrition—Methotrexate—colon cancer	0.00014	0.00126	CcSEcCtD
Atazanavir—Nausea—Vincristine—colon cancer	0.00014	0.00125	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00014	0.00125	CcSEcCtD
Atazanavir—Vomiting—Fluorouracil—colon cancer	0.00014	0.00125	CcSEcCtD
Atazanavir—Insomnia—Capecitabine—colon cancer	0.000139	0.00124	CcSEcCtD
Atazanavir—Rash—Fluorouracil—colon cancer	0.000138	0.00124	CcSEcCtD
Atazanavir—Dermatitis—Fluorouracil—colon cancer	0.000138	0.00124	CcSEcCtD
Atazanavir—Headache—Fluorouracil—colon cancer	0.000138	0.00123	CcSEcCtD
Atazanavir—Dysgeusia—Methotrexate—colon cancer	0.000137	0.00123	CcSEcCtD
Atazanavir—Dyspnoea—Capecitabine—colon cancer	0.000137	0.00123	CcSEcCtD
Atazanavir—Nausea—Irinotecan—colon cancer	0.000136	0.00122	CcSEcCtD
Atazanavir—Back pain—Methotrexate—colon cancer	0.000135	0.00121	CcSEcCtD
Atazanavir—Dyspepsia—Capecitabine—colon cancer	0.000135	0.00121	CcSEcCtD
Atazanavir—Decreased appetite—Capecitabine—colon cancer	0.000133	0.0012	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Capecitabine—colon cancer	0.000132	0.00119	CcSEcCtD
Atazanavir—Fatigue—Capecitabine—colon cancer	0.000132	0.00119	CcSEcCtD
Atazanavir—Pain—Capecitabine—colon cancer	0.000131	0.00118	CcSEcCtD
Atazanavir—Constipation—Capecitabine—colon cancer	0.000131	0.00118	CcSEcCtD
Atazanavir—Nausea—Fluorouracil—colon cancer	0.00013	0.00117	CcSEcCtD
Atazanavir—Ill-defined disorder—Methotrexate—colon cancer	0.00013	0.00116	CcSEcCtD
Atazanavir—Feeling abnormal—Capecitabine—colon cancer	0.000126	0.00113	CcSEcCtD
Atazanavir—Malaise—Methotrexate—colon cancer	0.000126	0.00113	CcSEcCtD
Atazanavir—Gastrointestinal pain—Capecitabine—colon cancer	0.000125	0.00113	CcSEcCtD
Atazanavir—Cough—Methotrexate—colon cancer	0.000122	0.0011	CcSEcCtD
Atazanavir—Urticaria—Capecitabine—colon cancer	0.000122	0.00109	CcSEcCtD
Atazanavir—Body temperature increased—Capecitabine—colon cancer	0.000121	0.00109	CcSEcCtD
Atazanavir—Abdominal pain—Capecitabine—colon cancer	0.000121	0.00109	CcSEcCtD
Atazanavir—Convulsion—Methotrexate—colon cancer	0.000121	0.00109	CcSEcCtD
Atazanavir—Arthralgia—Methotrexate—colon cancer	0.000119	0.00107	CcSEcCtD
Atazanavir—Myalgia—Methotrexate—colon cancer	0.000119	0.00107	CcSEcCtD
Atazanavir—Chest pain—Methotrexate—colon cancer	0.000119	0.00107	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000118	0.00106	CcSEcCtD
Atazanavir—Discomfort—Methotrexate—colon cancer	0.000118	0.00106	CcSEcCtD
Atazanavir—Confusional state—Methotrexate—colon cancer	0.000115	0.00103	CcSEcCtD
Atazanavir—Infection—Methotrexate—colon cancer	0.000113	0.00102	CcSEcCtD
Atazanavir—Hypersensitivity—Capecitabine—colon cancer	0.000113	0.00101	CcSEcCtD
Atazanavir—Nervous system disorder—Methotrexate—colon cancer	0.000112	0.001	CcSEcCtD
Atazanavir—Skin disorder—Methotrexate—colon cancer	0.000111	0.000995	CcSEcCtD
Atazanavir—Hyperhidrosis—Methotrexate—colon cancer	0.00011	0.000991	CcSEcCtD
Atazanavir—Asthenia—Capecitabine—colon cancer	0.00011	0.000988	CcSEcCtD
Atazanavir—Anorexia—Methotrexate—colon cancer	0.000109	0.000977	CcSEcCtD
Atazanavir—Pruritus—Capecitabine—colon cancer	0.000109	0.000974	CcSEcCtD
Atazanavir—Diarrhoea—Capecitabine—colon cancer	0.000105	0.000942	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000104	0.000934	CcSEcCtD
Atazanavir—Insomnia—Methotrexate—colon cancer	0.000103	0.000927	CcSEcCtD
Atazanavir—Dyspnoea—Methotrexate—colon cancer	0.000102	0.000914	CcSEcCtD
Atazanavir—Somnolence—Methotrexate—colon cancer	0.000102	0.000911	CcSEcCtD
Atazanavir—Dizziness—Capecitabine—colon cancer	0.000101	0.00091	CcSEcCtD
Atazanavir—Dyspepsia—Methotrexate—colon cancer	0.000101	0.000902	CcSEcCtD
Atazanavir—Decreased appetite—Methotrexate—colon cancer	9.93e-05	0.000891	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Methotrexate—colon cancer	9.86e-05	0.000885	CcSEcCtD
Atazanavir—Fatigue—Methotrexate—colon cancer	9.85e-05	0.000883	CcSEcCtD
Atazanavir—Pain—Methotrexate—colon cancer	9.77e-05	0.000876	CcSEcCtD
Atazanavir—Vomiting—Capecitabine—colon cancer	9.76e-05	0.000875	CcSEcCtD
Atazanavir—Rash—Capecitabine—colon cancer	9.67e-05	0.000868	CcSEcCtD
Atazanavir—Dermatitis—Capecitabine—colon cancer	9.67e-05	0.000867	CcSEcCtD
Atazanavir—Headache—Capecitabine—colon cancer	9.61e-05	0.000862	CcSEcCtD
Atazanavir—Feeling abnormal—Methotrexate—colon cancer	9.41e-05	0.000844	CcSEcCtD
Atazanavir—Gastrointestinal pain—Methotrexate—colon cancer	9.34e-05	0.000838	CcSEcCtD
Atazanavir—Nausea—Capecitabine—colon cancer	9.11e-05	0.000818	CcSEcCtD
Atazanavir—Urticaria—Methotrexate—colon cancer	9.07e-05	0.000814	CcSEcCtD
Atazanavir—Body temperature increased—Methotrexate—colon cancer	9.03e-05	0.00081	CcSEcCtD
Atazanavir—Abdominal pain—Methotrexate—colon cancer	9.03e-05	0.00081	CcSEcCtD
Atazanavir—Hypersensitivity—Methotrexate—colon cancer	8.42e-05	0.000755	CcSEcCtD
Atazanavir—Asthenia—Methotrexate—colon cancer	8.19e-05	0.000735	CcSEcCtD
Atazanavir—Pruritus—Methotrexate—colon cancer	8.08e-05	0.000725	CcSEcCtD
Atazanavir—Diarrhoea—Methotrexate—colon cancer	7.81e-05	0.000701	CcSEcCtD
Atazanavir—Dizziness—Methotrexate—colon cancer	7.55e-05	0.000678	CcSEcCtD
Atazanavir—Vomiting—Methotrexate—colon cancer	7.26e-05	0.000651	CcSEcCtD
Atazanavir—Rash—Methotrexate—colon cancer	7.2e-05	0.000646	CcSEcCtD
Atazanavir—Dermatitis—Methotrexate—colon cancer	7.2e-05	0.000645	CcSEcCtD
Atazanavir—Headache—Methotrexate—colon cancer	7.16e-05	0.000642	CcSEcCtD
Atazanavir—Nausea—Methotrexate—colon cancer	6.78e-05	0.000609	CcSEcCtD
